Description
What is Melatonin ?
Melatonin is a natural hormone produced mainly by the pineal gland in the brain.It regulates the body’s circadian rhythm, often referred to as the internal clock.This hormone signals to the body when it is time to sleep and when to wake up.Its release is influenced by light, increasing in darkness and decreasing in daylight.Melatonin binds to MT1 and MT2 receptors to control sleep–wake patterns.Beyond sleep, it also plays a role in antioxidant defense and cellular protection.Research suggests it influences metabolism, immune responses, and seasonal cycles.Overall, melatonin is a key regulator of biological rhythms and nighttime rest.
Melatonin Structure
Sequence: N-Acetyl-5-methoxytryptamine
Molecular Formula: C13H16N2O2
Molecular Weight: 232.28 g/mol
PubChem CID: 896
CAS Number: 73-31-4.
How Does Melatonin Work ?
Melatonin works as a key regulator of the body’s circadian rhythm, often referred to as the “biological clock.” It is primarily secreted by the pineal gland in response to darkness, with levels peaking at night to signal the body that it is time to sleep. This hormone acts by binding to melatonin receptors, MT1 and MT2, located in the brain’s suprachiasmatic nucleus (SCN) — the central clock that governs sleep-wake cycles. By influencing these receptors, melatonin helps synchronize daily physiological processes with the external day-night cycle, making it essential for regulating sleep onset and overall circadian timing.
Beyond sleep regulation, melatonin also plays roles in antioxidant defense, immune system modulation, and metabolic regulation. It helps neutralize free radicals, protecting cells from oxidative stress, and influences seasonal biological rhythms in some species. Because of these diverse actions, melatonin is not only considered a sleep-related hormone but also a multifunctional regulator that supports broader aspects of physiological balance.
Melatonin Research
Melatonin — Originally Identified for Circadian Regulation
Melatonin was first identified as a natural hormone produced by the pineal gland with a central role in regulating sleep–wake cycles and circadian rhythms. Its secretion is strongly tied to the light–dark cycle, rising during the night and falling during daylight hours.
Early research focused on its role in synchronizing biological rhythms, but investigators soon realized that melatonin also exerted antioxidant effects, immune modulation, and broader physiological influences beyond sleep regulation. This expanded its research interest from being simply a “sleep hormone” to a multifunctional regulator affecting diverse body systems.
Although the initial use was primarily focused on regulating sleep patterns and jet lag, clinical development soon expanded into potential applications in neurodegeneration, metabolic health, and seasonal affective disorder. This pathway of research reflects how a molecule first linked to circadian rhythm has been studied for a much wider range of physiological and clinical roles.
Because of these developments, melatonin’s research history is a blend of basic circadian biology and later disease-focused studies, illustrating how a naturally occurring hormone can be repurposed into broader health and clinical contexts when safety, delivery, and efficacy data support further exploration.
Melatonin Research and Blood Pressure
Studies have reported that melatonin can influence blood pressure regulation, often showing mild reductions in nighttime blood pressure due to its effects on vascular tone and autonomic balance. Because of this, cardiovascular parameters are frequently monitored in clinical trials involving melatonin.
Cognitive Decline, Alzheimer’s Disease, and Melatonin
Preclinical and clinical studies indicate that melatonin has neuroprotective potential. In models of Alzheimer’s-type pathology, melatonin reduces oxidative stress, modulates neuroinflammation, and supports neuronal survival. These effects contribute to improved cognitive outcomes in animal models and have prompted investigation into melatonin as an adjunctive therapy for age-related cognitive decline.
Mechanistically, melatonin interacts with MT1 and MT2 receptors in the brain, influencing pathways tied to neuronal plasticity, antioxidant defense, and regulation of inflammatory responses. This receptor-level activity provides a biological rationale for its protective signals in neurodegenerative conditions.
While the preclinical data are encouraging, translation into clinical benefit for human Alzheimer’s disease remains under investigation. Controlled human trials are still needed to fully establish safety, dosing, and efficacy in this setting.
Melatonin and Functional Recovery Following Stroke
Experimental studies suggest melatonin may aid functional recovery after ischemic stroke, owing to its antioxidant and anti-apoptotic properties. Preliminary clinical data point to potential improvements in recovery and reduced tissue damage, though these findings remain early-stage and require confirmation in larger, controlled trials.
Melatonin’s Influence on Heart and Circulation
Beyond sleep regulation, melatonin affects the cardiovascular system by modulating vascular tone, sympathetic nervous activity, and inflammation. Because melatonin receptors are expressed in blood vessels and heart tissues, its influence on circulation and cardiac function is a consistent area of research interest.
Melatonin Research and Neuroinflammatory Disease
Melatonin demonstrates broad anti-inflammatory and neuroprotective properties. It reduces the production of pro-inflammatory cytokines, modulates microglia and astrocyte activity, and helps maintain redox balance in the central nervous system. These effects make it a candidate of interest for conditions involving neuroinflammation and neurodegeneration.
Although mechanistic and preclinical evidence is strong, translation to clinical practice is still ongoing. Researchers emphasize the importance of dose, treatment timing, and patient characteristics when evaluating melatonin’s role in neuroinflammatory conditions.
Melatonin Investigated in Metabolism and Weight Regulation
Some studies have noted that melatonin influences energy metabolism, appetite regulation, and body composition. Animal models suggest possible effects on fat storage and glucose homeostasis. However, these findings remain primarily experimental; clinically approved weight-management therapies are based on other mechanisms, and melatonin’s role in fat loss remains a research observation rather than an established indication.